CYP39A1 and early-onset autosomal dominant Alzheimer disease: Increasing the expression of CYP39A1 could be beneficial to reduce brain 24S-hydroxycholesterol, whose accumulation has been shown to be related to oxidative stress and reported in the brain of patients with dementia and Alzheimer’s disease (Matsuoka et al., 2020).